Genentech Inc:企業の戦略的SWOT分析

◆英語タイトル:Genentech Inc - Strategic SWOT Analysis Review
◆商品コード:DATA904C15787
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Genentech Inc – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Genentech Inc (Genentech), a subsidiary of F. Hoffmann-La Roche Ltd, is a biotechnology company that discovers, develops, manufactures and commercializes medicines to address serious medical needs. It offers drugs in various therapeutic areas including bio-oncology, immunology, ophthalmology, metabolism, primary care, neurology, virology, hematology and specialty care. Its pipeline products include Emicizumab (RG6013, ACE910), a bispecific monoclonal antibody used to replace the function of protein in the blood clotting process; and other products. The company has partnership with BioLineRx, Charles River Laboratories International and Amunix, among others. Genentech is headquartered in South San Francisco, California, the US.

Genentech Inc Key Recent Developments

Mar 11,2019 Susan G. Komen Announces New Funding Opportunity Focused on Better Understanding of Breast Cancer Disparities
Feb 11,2019 Samsung Bioepis forms new alliance to expand in China
Feb 06,2019 Xencor and Genentech partner on novel IL-15 cytokine drugs
Jan 24,2019 Genentech announces Alexander Hardy as Chief Executive Officer
Jan 17,2019 PhRMA welcomes Genentech and Gilead Sciences to association

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Genentech Inc – Key Facts
Genentech Inc – Key Employees
Genentech Inc – Key Employee Biographies
Genentech Inc – Major Products and Services
Genentech Inc – History
Genentech Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Genentech Inc – Business Description
Genentech Inc – SWOT Analysis
SWOT Analysis – Overview
Genentech Inc – Strengths
Genentech Inc – Weaknesses
Genentech Inc – Opportunities
Genentech Inc – Threats
Genentech Inc – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Genentech Inc, Recent Deals Summary
Section 4 – Company’s Recent Developments
Mar 11, 2019: Susan G. Komen Announces New Funding Opportunity Focused on Better Understanding of Breast Cancer Disparities
Feb 11, 2019: Samsung Bioepis forms new alliance to expand in China
Feb 06, 2019: Xencor and Genentech partner on novel IL-15 cytokine drugs
Jan 24, 2019: Genentech announces Alexander Hardy as Chief Executive Officer
Jan 17, 2019: PhRMA welcomes Genentech and Gilead Sciences to association
Jan 09, 2019: NIIMBL Announces New Projects to Advance Biopharmaceutical Manufacturing
Nov 28, 2018: Roche subsidiary Genentech to acquire Jecure Therapeutics
Oct 04, 2018: Positive Phase III Results for Baloxavir Marboxil in People at High Risk of Complications From Influenza to be Presented at IDWeek 2018
Sep 13, 2018: FDA Approves Subcutaneous Formulation of Actemra for Use in Active Systemic Juvenile Idiopathic Arthritis (SJIA), a Rare Form of Juvenile Arthritis[Newswire : Healthcare-BW]
Jul 19, 2018: Genentech to present new data demonstrating the breadth and depth of its alzheimer’s program at the upcoming Alzheimer’s Association International Conference (AAIC)
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Genentech Inc, Key Facts
Genentech Inc, Key Employees
Genentech Inc, Key Employee Biographies
Genentech Inc, Major Products and Services
Genentech Inc, History
Genentech Inc, Other Locations
Genentech Inc, Key Competitors
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Genentech Inc, Recent Deals Summary

List of Figures
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Genentech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Genentech Inc:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Wright Medical Group NV (WMGI)-医療機器分野:企業M&A・提携分析
    Summary Wright Medical Group NV (Wright) is an international orthopedic medical device company with focus on extremity and biologic solutions. The company designs, manufactures and markets reconstructive joint devices including extremity implants for the shoulder, elbow, foot, ankle and hand; foot a …
  • Aptevo Therapeutics Inc (APVO):企業の財務・戦略的SWOT分析
    Aptevo Therapeutics Inc (APVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • IMPARAT Farbwerk Iversen & Mahl GmbH & Co KG:企業の戦略・SWOT・財務情報
    IMPARAT Farbwerk Iversen & Mahl GmbH & Co KG - Strategy, SWOT and Corporate Finance Report Summary IMPARAT Farbwerk Iversen & Mahl GmbH & Co KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Molinos Rio de la Plata SA (MOLI3):企業の財務・戦略的SWOT分析
    Molinos Rio de la Plata SA (MOLI3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Chiyoda Corp (6366):企業の財務・戦略的SWOT分析
    Chiyoda Corp (6366) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Harland Medical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary Harland Medical Systems Inc (Harland Medical) is a medical equipment provider that offers medical device coatings. The company offers test equipment, coating systems, laser equipment and dispensing equipment. Its products comprise lubricent UV hydrophilic coatings, bacticent antimicrobial co …
  • Sembcorp Industries Ltd (U96):企業の財務・戦略的SWOT分析
    Sembcorp Industries Ltd (U96) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Sumitomo Chemical Co., Ltd.:企業の戦略・SWOT・財務情報
    Sumitomo Chemical Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Chemical Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • AGL Energy Ltd (AGL)-エネルギー分野:企業M&A・提携分析
    Summary AGL Energy Limited (AGL) is an integrated energy company that owns, operates and develops energy assets and provides natural gas, electricity, solar photovoltaic solutions and related products and services. The company’s power generation portfolio includes coal, gas, hydro, wind, solar, land …
  • Genome Institute of Singapore:製薬・医療:M&Aディール及び事業提携情報
    Summary Genome Institute of Singapore (GIS) is a research institute that provides research programs and services in different areas. The institute concentrates on genomic sciences to improve public health and prosperity in Singapore. It operates technology and comprises early career researchers such …
  • Empresas Copec SA (COPEC):企業の財務・戦略的SWOT分析
    Empresas Copec SA (COPEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Taikisha Ltd:企業の戦略・SWOT・財務分析
    Taikisha Ltd - Strategy, SWOT and Corporate Finance Report Summary Taikisha Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Specialist Computer Centres Plc:企業の戦略・SWOT・財務情報
    Specialist Computer Centres Plc - Strategy, SWOT and Corporate Finance Report Summary Specialist Computer Centres Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Veran Medical Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Veran Medical Technologies Inc (Veran) is a medical device company that develops products for minimally invasive delivery of interventional oncology therapies. The company provides endobronchial products such as SpiN thoracic navigation system, Always-On tip tracked instruments, SpiNPerc and …
  • Ck Hutchison Holdings Ltd
    Ck Hutchison Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Ck Hutchison Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Iconic Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Iconic Therapeutics Inc (Iconic Therapeutics) is a biopharmaceutical company that provides translation of scientific insight into breakthrough medicines. The company offers development of tissue factor in inflammation, angiogenesis, and metastasis that led to develop new approach to retinal …
  • BASF Corp:企業のM&A・事業提携・投資動向
    BASF Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BASF Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Refresco Gerber B.V.:戦略・SWOT・企業財務分析
    Refresco Gerber B.V. - Strategy, SWOT and Corporate Finance Report Summary Refresco Gerber B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Bio Techne Corp (TECH)-医療機器分野:企業M&A・提携分析
    Summary Bio Techne Corp (Bio Techne), develops manufactures and sells biotechnology products and instruments for research and clinical diagnostics. The company provides proteins and antibodies, and related immunoassays and other reagents for research under brands such as R&D Systems, Novus, Biologic …
  • Griffon Corporation:企業の戦略・SWOT・財務分析
    Griffon Corporation - Strategy, SWOT and Corporate Finance Report Summary Griffon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆